Literature DB >> 19542605

The role of neuropsychology in distinguishing the posterior cortical atrophy syndrome and Alzheimer's disease.

Anna Aresi1, Anna Rita Giovagnoli.   

Abstract

This study investigated the neuropsychological hallmarks of posterior cortical atrophy (PCA). Seventeen patients with PCA, 17 patients with probable Alzheimer's disease (PAD), and 17 healthy age-matched subjects underwent neuropsychological testing for abstract reasoning, visuospatial abilities, memory, language, executive functions, praxes, and attention. The PCA patients were significantly more impaired in visual perception, spatial memory, visual attention, and visuospatial reasoning compared to the PAD patients who were relatively more impaired in episodic memory. In the PCA group, no test score correlated with disease duration or age of clinical onset, whereas, in the PAD group, several scores correlated with disease duration. Compared to the healthy subjects, both patient groups showed multiple cognitive deficits. Thus, PCA is characterised by distinctive visuospatial deficits that reflect the distribution of brain damage and contrast with the memory impairment of PAD patients. Specific neuropsychological tests may contribute to early identification of cortical dementia for diagnostic and research purposes.

Entities:  

Mesh:

Year:  2009        PMID: 19542605     DOI: 10.3233/JAD-2009-1123

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  3 in total

1.  Functional neural substrates of posterior cortical atrophy patients.

Authors:  H Shames; N Raz; Netta Levin
Journal:  J Neurol       Date:  2015-05-16       Impact factor: 4.849

2.  Cognitive training in Alzheimer's disease: a controlled randomized study.

Authors:  A R Giovagnoli; V Manfredi; A Parente; L Schifano; S Oliveri; G Avanzini
Journal:  Neurol Sci       Date:  2017-06-02       Impact factor: 3.307

3.  Posterior AD-type pathology: cognitive subtypes emerging from a cluster analysis.

Authors:  Antonella Cappa; Nicoletta Ciccarelli; Eleonora Baldonero; Marialuisa Martelli; Maria Caterina Silveri
Journal:  Behav Neurol       Date:  2014-06-05       Impact factor: 3.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.